Мақаланы E-mail арқылы жіберу Effect of Vascular Endothelial Growth Factor and Erythropoietin on Functional Activity of Fibroblasts and Multipotent Mesenchymal Stromal Cells
- Авторлар: Bondarenko N.1,2, Nikonorova Y.1, Surovtseva M.1, Lykov A.1,2, Poveshchenko O.1,2, Poveshchenko A.1,2, Pokushalov E.2, Romanov A.2, Konenkov V.1,2
-
Мекемелер:
- Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
- E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
- Шығарылым: Том 160, № 4 (2016)
- Беттер: 498-501
- Бөлім: Experimental Biology
- URL: https://journals.rcsi.science/0007-4888/article/view/236755
- DOI: https://doi.org/10.1007/s10517-016-3206-8
- ID: 236755
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
The study examined the effect of VEGF and erythropoietin on proliferative and migratory activities of skin fibroblasts and multipotent mesenchymal stromal cells of human adipose tissue. VEGF stimulated proliferation and migration of fi broblasts, but produced no significant effect on functional activity of multipotent mesenchymal stem cells. Erythropoietin stimulated proliferation of both cell types, but did not affect their migration.
Авторлар туралы
N. Bondarenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Хат алмасуға жауапты Автор.
Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk
Yu. Nikonorova
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
Ресей, Moscow
M. Surovtseva
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
Ресей, Moscow
A. Lykov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk
O. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk
A. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk
E. Pokushalov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Ресей, Novosibirsk
A. Romanov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Ресей, Novosibirsk
V. Konenkov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Ресей, Moscow; Novosibirsk
